Science Applications International Corporation
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Science Applications International Corporation.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 82.20 $ to 133.70 $ · Last price: 133.70 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Information Technology Services
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Science Applications International Corporation SAIC | 5.6 | 15.4 | 11.0 | 12.7 | 8.8 | -2.9 | 31.9 |
| International Business Machines IBM | 212.8 | 21.3 | 16.3 | 58.1 | 13.8 | 7.6 | -5.9 |
| Accenture plc ACN | 117.9 | 15.3 | 9.0 | 32.0 | 17.0 | 7.4 | -18.5 |
| Infosys Ltd INFY | 45.0 | 13.7 | 9.0 | 29.7 | 21.2 | 4.6 | -32.7 |
| Cognizant Technology Solutions Corporation CTSH | 29.3 | 13.1 | 7.3 | 33.4 | 15.6 | 7.0 | -9.6 |
| CDW Corp CDW | 19.1 | 17.3 | 12.4 | 21.4 | 6.6 | 6.8 | -9.0 |
| Broadridge Financial Solutions Inc BR | 19.0 | 17.6 | 12.1 | 31.8 | 18.4 | 5.9 | -31.4 |
| Fidelity National Information Services, Inc. FIS | 18.8 | 7.2 | 9.6 | 35.8 | 16.4 | 5.4 | -43.7 |
| Wipro Limited WIT | 16.6 | 12.9 | 7.4 | 29.0 | 15.7 | 4.0 | -37.3 |
| Median of companies shown | 19.1 | 15.3 | 9.6 | 31.8 | 15.7 | 5.9 | -18.5 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 4,442 | 263 | 143 | 3.12 | 273 | 349 | 2,042 |
| 2018 | 4,454 | 256 | 179 | 4.02 | 217 | 327 | 2,073 |
| 2019 | 4,659 | 220 | 137 | 3.11 | 184 | 1,499 | 4,563 |
| 2020 | 6,379 | 370 | 226 | 3.83 | 458 | 1,418 | 4,711 |
| 2021 | 7,056 | 390 | 209 | 3.56 | 755 | 1,542 | 5,723 |
| 2022 | 7,394 | 462 | 277 | 4.77 | 518 | 1,619 | 5,746 |
| 2023 | 7,704 | 501 | 300 | 5.38 | 532 | 1,694 | 5,543 |
| 2024 | 7,444 | 741 | 477 | 8.88 | 396 | 1,785 | 5,314 |
| 2025 | 7,479 | 539 | 362 | 7.17 | 494 | 1,577 | 5,246 |
| 2026 | 7,262 | 524 | 358 | 7.70 | 609 | 1,500 | 5,354 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2025: Q1 | 2.00 | 170.30 | 1,838 | 5.80 | 5.30 | 115 | 100 |
| 2025: Q2 | 1.42 | -3.70 | 1,877 | 1.60 | 3.60 | 100 | 100 |
| 2025: Q3 | 2.71 | 71.50 | 1,769 | -2.70 | 7.20 | 122 | 115 |
| 2025: Q4 | 1.66 | -21.90 | 1,866 | -5.60 | 4.20 | 129 | 144 |
| 2026: Q1 | 1.87 | -6.40 | 1,750 | -4.80 | 4.90 | 258 | 250 |
| 2026: Q2 | 2.61 | 83.70 | 1,906 | 1.50 | 6.00 | 127 | 118 |
| 2026: Q3 | 2.38 | -12.20 | 1,880 | 6.30 | 5.40 | 146 | 131 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 10 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
Breakout & Setup
Earnings & Surprises
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 01/31/2027 | 10.81 | 10.70 – 11.06 | 7,297 | 0.6% | 10 |
| 01/31/2028 | 11.48 | 10.24 – 12.26 | 7,397 | 6.2% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly -3.4% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $619.0M |
|---|---|
| Market cap | $5.56B |
| Free cash flow in year ten | $439.3M |
| Terminal value as a share of market value | 41.6% |
For comparison: over the past five years free cash flow shrank by 4.0% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -2.0%
- More than 10% revenue growth is expected for the coming year 1.0%
- Share count grows by less than 3% a year -5.9%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 5.0%
- Gross margin at 40% or higher and without meaningful erosion 12.1%
- Goodwill from acquisitions does not grow faster than revenue 55.0%
- Net debt below twice EBITDA 3.8 x EBITDA
- Operating cash flow covers the profits of the last three years 302 m
- Return on capital at 15% or higher, or up versus two years ago 12.0%
- Insiders hold at least 10% or are net buyers 0.8%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
6/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 5.6%
- Exp. sales growth 3Y > 5% 0.9%
- EBIT growth 10Y > 5% 8.0%
- Exp. EBIT growth 3Y > 5% 22.1%
- Net debt < 4x EBIT 4.8x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 29.3%
- Return on equity > 15% –
- ROCE > 15% 12.0%
- Expected return > 10% 34.8%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Benson David C | Director | Other | 1,220 | 0.00 | – |
| Sep 4, 2026 | DiFronzo Vincent P. | EVP,-Air Force & Space, Intel | Other | 4,210 | 0.00 | – |
| Sep 4, 2026 | Cush C. David | Director | Other | 1,220 | 0.00 | – |
The company
About the Company
Science Applications International Corporation erbringt technische, ingenieurtechnische sowie Mission- und Enterprise-IT-Dienstleistungen in den USA. Sie ist in zwei Segmenten tätig: Defense and Intelligence sowie Civilian.
- Employees
- 23,000
- Headquarters
- Reston, VA
- Address
- 12010 Sunset Hills Road, 20190 Reston, United States
- Phone
- 703 676 4300
- Website
- saic.com
- IPO Date
- 09/16/2013
- ISIN
- US8086251076
Management
| Name | Title | Birth Year |
|---|---|---|
| James C. Reagan CPA | CEO & Director | 1959 |
| Hilary L. Hageman J.D. | Executive VP, General Counsel & Corporate Secretary | 1969 |
| Kathleen T. McCarthy | Executive VP & Chief Human Resources Officer | – |
| Bob Ritchie | Senior VP & Chief Technology Officer | – |
| Nathan G. Rogers | Chief Information Officer | – |
| Jonathan Phaff Raviv | Vice President of Investor Relations | – |
| Paul H. Greiner | Senior VP & Deputy General Counsel | – |
| John Bonsell | Senior Vice President of Government Affairs | – |
| Maria M. Bishop | Senior Vice President of Internal Audit & Internal Controls | 1963 |
| Mark Escobar | Executive VP & Chief of Business Operations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/31/2026 Science Applications International Corp (SAIC): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 08/28/2026 Science Applications International Corp (SAIC): Other Events; Financial Statements and Exhibits SEC ↗
- 08/19/2026 Science Applications International Corp (SAIC): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗
- 08/10/2026 Science Applications International Corp (SAIC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.